World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
97
Citations
30534
World Ranking
9386
National Ranking
106

Overview

Filip K. Knop is affiliated with the University of Copenhagen in Denmark and has a substantial research output primarily in the field of Medicine, with a strong focus on Endocrinology, Diabetes, and Metabolism. Their work spans subfields including Surgery, Molecular Biology, Physiology, and Epidemiology, reflecting a multidisciplinary approach to their research topics.

The main topics covered in Knop's research encompass Diabetes Treatment and Management, Diabetes Management and Research, Pancreatic Function and Diabetes, Diet and Metabolism Studies, Metabolism related to Diabetes and Cancer, Liver Disease Diagnosis and Treatment, and Diabetes and Associated Disorders. These thematic areas reveal a focus on metabolic diseases and their management, with emphasis on both clinical and physiological aspects.

Knop has contributed to various scientific journals, with frequent publications in the following venues:

  • Diabetes
  • Diabetes Obesity and Metabolism
  • European Journal of Endocrinology
  • The Journal of Clinical Endocrinology & Metabolism
  • Diabetologia

A selection of recent papers authored or co-authored by Knop includes:

  • Oral semaglutide 50 mg taken once per day in adults with overweight or obesity (OASIS 1): a randomised, double-blind, placebo-controlled, phase 3 trial, 2023, The Lancet

Knop frequently collaborates with several researchers, notably:

  • Tina Vilsbøll
  • Jens J. Holst
  • Bolette Hartmann
  • Asger Lund
  • Mikkel Christensen

Best Publications

  • Effects of glucagon-like peptide-1 receptor agonists on weight loss: systematic review and meta-analyses of randomised controlled trials

    Tina Vilsbøll;Mikkel Christensen;Anders E Junker;Filip K Knop

  • Improvement of Insulin Sensitivity after Lean Donor Feces in Metabolic Syndrome Is Driven by Baseline Intestinal Microbiota Composition

    Ruud S. Kootte;Evgeni Levin;Jarkko Salojärvi;Loek P. Smits

  • Recovery of gut microbiota of healthy adults following antibiotic exposure

    Albert Palleja;Kristian H Mikkelsen;Sofia K Forslund;Alireza Kashani

  • Impact of oral vancomycin on gut microbiota, bile acid metabolism, and insulin sensitivity

    Anne Vrieze;Carolien Out;Susana Fuentes;Lisanne Jonker

  • Four weeks of near-normalisation of blood glucose improves the insulin response to glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide in patients with type 2 diabetes.

    P. V. Højberg;P. V. Højberg;T. Vilsbøll;R. Rabøl;F. K. Knop

  • Reduced incretin effect in type 2 diabetes: cause or consequence of the diabetic state?

    Filip K. Knop;Tina Vilsbøll;Patricia V. Højberg;Steen Larsen

  • Glucagon-like peptide 1 in health and disease.

    Andreas Andersen;Asger Lund;Filip K. Knop;Tina Vilsbøll

  • Glucose-Dependent Insulinotropic Polypeptide: A Bifunctional Glucose-Dependent Regulator of Glucagon and Insulin Secretion in Humans

    Mikkel Christensen;Louise Vedtofte;Jens J. Holst;Tina Vilsbøll

  • The glucagonostatic and insulinotropic effects of glucagon-like peptide 1 contribute equally to its glucose-lowering action.

    Kristine J. Hare;Tina Vilsbøll;Meena Asmar;Carolyn F. Deacon

  • The pathophysiology of diabetes involves a defective amplification of the late-phase insulin response to glucose by glucose-dependent insulinotropic polypeptide-regardless of etiology and phenotype

    T. Vilsbøll;F. K. Knop;T. Krarup;A. Johansen

  • Loss of Incretin Effect Is a Specific, Important, and Early Characteristic of Type 2 Diabetes

    Jens J. Holst;Filip K. Knop;Tina Vilsbøll;Thure Krarup

  • Secretion of glucagon-like peptide-1 in patients with type 2 diabetes mellitus: systematic review and meta-analyses of clinical studies

    S. Calanna;S. Calanna;M. Christensen;J. J. Holst;B. Laferrère

  • 2-Oleoyl glycerol is a GPR119 agonist and signals GLP-1 release in humans.

    Katrine B. Hansen;Mette M. Rosenkilde;Filip K. Knop;Niels Wellner

  • Impaired Regulation of the Incretin Effect in Patients with Type 2 Diabetes

    Jonatan I. Bagger;Filip K. Knop;Asger Lund;Henrik Vestergaard

  • Benefits and Harms of Sodium-Glucose Co-Transporter 2 Inhibitors in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis.

    Heidi Storgaard;Lise L. Gluud;Cathy Bennett;Magnus F. Grøndahl

  • Inappropriate suppression of glucagon during OGTT but not during isoglycaemic i.v. glucose infusion contributes to the reduced incretin effect in type 2 diabetes mellitus.

    F. K. Knop;T. Vilsbøll;S. Madsbad;J. J. Holst

  • Plasma proteome profiling discovers novel proteins associated with non-alcoholic fatty liver disease.

    Lili Niu;Lili Niu;Philipp E Geyer;Philipp E Geyer;Nicolai J Wewer Albrechtsen;Lise L Gluud

  • Impaired incretin effect and fasting hyperglucagonaemia characterizing type 2 diabetic subjects are early signs of dysmetabolism in obesity

    F K Knop;K Aaboe;T Vilsbøll;Anders Vølund

  • The separate and combined impact of the intestinal hormones, GIP, GLP-1, and GLP-2, on glucagon secretion in type 2 diabetes.

    Asger Lund;Tina Vilsbøll;Jonatan I. Bagger;Jens J. Holst

  • The effect of exogenous GLP-1 on food intake is lost in male truncally vagotomized subjects with pyloroplasty

    Astrid Plamboeck;Simon Veedfald;Carolyn F. Deacon;Bolette Hartmann

Frequent Co-Authors

Jens J. Holst
Jens J. Holst University of Copenhagen
Sten Madsbad
Sten Madsbad University of Copenhagen
Jens F. Rehfeld
Jens F. Rehfeld University of Copenhagen
Mette M. Rosenkilde
Mette M. Rosenkilde University of Copenhagen
Carolyn F. Deacon
Carolyn F. Deacon University of Copenhagen
Lise Lotte Gluud
Lise Lotte Gluud University of Copenhagen
Torben Hansen
Torben Hansen University of Copenhagen
Lone Skov
Lone Skov University of Copenhagen
Gunnar H. Gislason
Gunnar H. Gislason Copenhagen University Hospital
Matthias Mann
Matthias Mann Max Planck Institute of Biochemistry

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in Medicine isn’t limited to becoming a doctor. There are many related online degrees and flexible career pathways that can complement or diversify your future in healthcare.

Advanced nurses looking to step into leadership or specialized clinical roles should consider the best dnp programs online. These affordable online programs offer doctorate-level training for those seeking career advancement in nursing.

For those interested in the pharmaceutical field, online pharmacy school programs offer a route to reach the top of pharmacy practice and research, with flexible schedules suitable for working professionals.

If you’re drawn towards health data, enrolling in online rhit degree programs can prepare you for roles in medical records and health information management—an area crucial to modern healthcare systems.

Finally, those looking for accessible and in-demand roles should consider a low cost medical coding and billing online program. This affordable path leads to rapid job opportunities in clinics, hospitals, and insurance organizations.

Best Scientists Citing Filip K. Knop

Trending Scientists